Pasquale Stefanizzi
Overview
Explore the profile of Pasquale Stefanizzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Lorenzo A, Triggiano F, Lopuzzo M, Piccolomo L, Triggiani M, Grasso S, et al.
IJID Reg
. 2024 Nov;
13:100468.
PMID: 39507392
Objectives: has been circulating since 2019 in Northern and Middle-Italy regions. Design: This report details the first three cases of isolation in Puglia (Southern Italy), which occurred as a nosocomial...
2.
De Virgilio Suglia C, Stefanizzi P, Graziano G, Moscara L, Delle Fontane A, Minelli M, et al.
Hum Vaccin Immunother
. 2024 Sep;
20(1):2403831.
PMID: 39288786
This retrospective cohort study evaluated the effectiveness of maternal vaccination against COVID-19 in reducing the risk of SARS-CoV-2 infection in infants younger than 12 months. The study, conducted at the...
3.
Palmieri C, Moscara L, Tafuri S, Stefanizzi P
Hum Vaccin Immunother
. 2024 Sep;
20(1):2396220.
PMID: 39263919
Two vaccines are available to prevent serogroup B meningococcal disease, i.e. the four-component meningococcal serogroup B vaccine (4CMenB) and the bivalent-factor-H-binding-protein meningococcal serogroup B vaccine (MenB-fHbp). Currently, 4CMenB is offered...
4.
Di Lorenzo A, Capodiferro L, Illuzzi M, Scaltrito C, Vimercati L, Moscara L, et al.
Vaccine X
. 2024 Aug;
19:100530.
PMID: 39157686
Pertussis is a vaccine-preventable respiratory disease. Pertussis vaccination is currently mandatory for all children in Italy, and is administered in three doses at the beginning of the third, fifth, and...
5.
Comparcini D, Tomietto M, Pastore F, Nichol B, Miniscalco D, Flacco M, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066410
Vaccination among pregnant and breastfeeding women is critical for protecting this vulnerable population and their children. COVID-19 vaccination is recommended both during pregnancy and breastfeeding; however, we still do not...
6.
Stefanizzi P, Di Lorenzo A, Capodiferro L, Moscara L, Noviello C, Vimercati L, et al.
Vaccine
. 2024 Jul;
42(24):126098.
PMID: 39013692
Influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are respiratory pathogens which significantly impact healthcare systems. Seasonal vaccination is recommended for all healthcare workers (HCWs) to reduce the risk...
7.
Caggiano G, Fioriti S, Morroni G, Apollonio F, Triggiano F, DAchille G, et al.
J Infect Public Health
. 2024 Apr;
17(6):967-974.
PMID: 38631066
Background: Candidemia is the most common healthcare associated invasive fungal infection. Over the last few decades, candidemia caused by Candida species other than Candida albicans, particularly the Candida parapsilosis complex,...
8.
Stefanizzi P, Moscara L, Palmieri C, Martinelli A, Di Lorenzo A, Venerito V, et al.
Vaccine
. 2024 Apr;
42(12):2966-2974.
PMID: 38582693
Background: Since 2021 a recombinant adjuvanted anti-Herpes Zoster vaccine(Recombinant Zoster Vaccine, RZV) is offered in Italy to high-risk patients. Few real-life data about RZV safety are available in target populations....
9.
Valeriani F, Masini A, Baldelli G, Dallolio L, Eid L, Lovecchio N, et al.
Ann Ig
. 2024 Apr;
36(5):581-587.
PMID: 38567705
Background: Regular physical activity is crucial in preventing chronic diseases. International health authorities recommend that children and adolescents engage in at least 60 minutes of moderate to vigorous physical activity...
10.
Bianchi F, Rizzi D, Daleno A, Stefanizzi P, Migliore G, Tafuri S
Int J Infect Dis
. 2024 Feb;
141:106960.
PMID: 38365084
Objective: In 2021, the US Centers for Disease Control and Prevention reported increased cases of myocarditis and pericarditis in the United States after mRNA COVID-19 vaccines. Our study aims to...